GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.

GENIL | IS

Overview

Corporate Details

ISIN(s):
TREGENL00016 (+1 more)
LEI:
789000A4NW6W4D8Z4H25
Country:
Türkiye
Address:
MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1998, GEN İlaç ve Sağlık Ürünleri is a pharmaceutical company focused on providing global solutions for rare diseases and unmet health needs. The company leverages over 25 years of experience through a versatile business model that includes strategic partnerships with global firms and in-house development. It operates its own GMP-certified production facility and R&D center to create and manufacture competitive products for international markets. GEN specializes in treatments within key therapeutic areas such as neurology, endocrinology, nephrology, oncology, and hematology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 13:38
Regulatory Filings
Signature of New Distributorship Agreement
Turkish 35.8 KB
2025-11-24 09:40
Regulatory Filings
Employee Experience Survey Result
Turkish 215.5 KB
2025-11-24 09:40
Environmental & Social Information
Employee Experience Survey Result
Turkish 18.4 KB
2025-11-18 16:04
Share Issue/Capital Change
Participation in Subsidiary Capital Increase
Turkish 19.8 KB
2025-11-12 11:44
Board/Management Information
Company General Info Form
Turkish 3.8 KB
2025-11-11 12:55
Board/Management Information
Appointment of Investor Relations Manager
Turkish 18.1 KB
2025-11-10 13:58
Notice of Dividend Amount
Kar Payının 3. Taksitinin Ödenmesi
Turkish 358.5 KB
2025-11-10 13:58
Notice of Dividend Amount
Kar Payının 3. Taksitinin Ödenmesi
English 38.6 KB
2025-11-10 06:03
Annual / Quarterly Financial Statement
01.01.2025 - 30.09.2025 Sorumluluk Beyanı
Turkish 19.9 KB
2025-11-10 06:03
Quarterly Report
01.01.2025 - 30.09.2025 Interim Period Activity Report
English 1.1 MB
2025-11-10 06:03
Interim / Quarterly Report
01.01.2025 - 30.09.2025 Interim Period Activity Report
Turkish 2.0 MB
2025-11-10 06:03
Report Publication Announcement
01.01.2025 - 30.09.2025 Interim Period Activity Report
English 11.5 KB
2025-11-10 06:03
Quarterly Report
Financial Report
Turkish 2.6 MB
2025-11-10 06:03
Annual / Quarterly Financial Statement
Financial Report
English 2.6 MB
2025-10-21 18:22
Annual / Quarterly Financial Statement
Company General Info Form
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900

Talk to a Data Expert

Have a question? We'll get back to you promptly.